2008-07-03 02:11:20 -
www.companiesandmarkets.com adds new report - Rigel Pharmaceuticals, Inc. - SWOT Analysis www.companiesandmarkets.com/Summary-Company-Profile/Rigel-Pharma ..
Rigel Pharmaceuticals, Inc. - SWOT Analysis Company Profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Rigel is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs
for the treatment of inflammatory diseases and cancer, as well as viral and metabolic diseases. The company has product development programs in inflammatory/autoimmune diseases such as rheumatoid arthritis, thrombocytopenia and asthma, as well as oncology. Rigel is headquartered in San Francisco, California and employs approximately 150 people. The company recorded revenues of $33 million during the fiscal year ended December 2006, an increase of 102.5% over 2005. The operating loss of the company was $43 million during fiscal year 2006, an improvement of 10.1% over 2005. The net loss in fiscal year 2006 was $38 million, an improvement of 16.8% over 2005.
Scope of the Report
- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement
Reasons to Purchase
- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available
